Layer 1

Help your patients manage joint pain effectively

Brought to you by

Help your patients manage joint pain effectively

Joint pain is an extremely common cause of pain and disability; in fact one in three UK adults over the age of 45 are seeking treatment for it1. As part of this, Osteoarthritis (OA) is the most common cause of mechanical joint pain1 with over 8.75 million people aged 45 and over having sought treatment for it2. With increasing life expectancy and an ever-growing incidence of obesity in the UK2, the role of the pharmacy team in the management of joint pain looks set to continue to rise3; how can you help your patients overcome this and give them back the joy of movement?

GSK, the manufacturer of Voltarol, the market leading topical NSAID in pharmacy4, has a mission to help people do more, feel better, live longer and has a responsibility to ensure the appropriate use of medicines and care for patients.

Voltarol provides clinically proven relief to patients with joint pain. The Voltarol range, available in different formats such as medicated gel, plaster and non-medicated heat patch, can also provide relief for other types of body pain, including muscle and neck pain.

Dr Soha Dattani, Director Scientific Affairs Consumer Healthcare, comments: “National Arthritis Week puts a spotlight on this growing condition which affects millions of people across the UK, impacting their everyday lives. OA is one of the most common form of arthritis5. Community pharmacists are in a unique and trusted position to play a bigger role in front line management, to support joint pain sufferers and help them live a fuller life.

“With Voltarol being the topical NSAID market leader in pharmacies4, we are committed to supporting pharmacy staff manage joint pain effectively.”

GSK is helping pharmacy teams fully understand the condition and how they can help their patients treat it. For more information, please visit: www.jointpainpartners.gsk.com.

Voltarol Osteoarthritis Joint Pain Relief 1.16% Gel (diclofenac diethylammonium): 100 g £11.24 (excl. VAT). Click here for product information.

Voltarol 12 Hour Joint Pain Relief 2.32% Gel (diclofenac diethylammonium): 100g £15.58 (excl. VAT). Click here for product information.

Voltarol 140mg Medicated Plaster (diclofenac sodium): 2s £8.25, 5s £15.83 (excl. VAT). Click here for product information.

References
  1. Osteoarthritis in General Practice - Data and Perspectives. Arthritis Research UK
  2. https://www.arthritisresearchuk.org/arthritis-information/data-and-statistics/state-of-musculoskeletal-health/what-is-the-scale-of-the-problem.aspx
  3. Fernandes L, Hagen K, Bijlsma J et al. Ann Rheum Dis 2012; 72 (7): 125-35
  4. Nielsen Pain Market Summary, Total Chemists, Unit % Share, L12W, WE 07.09.2019
  5. NIH Osteoporosis and related bone diseases national resource centre, https://www.bones.nih.gov/health-info/bone/osteoporosis/conditions-behaviors/osteoporosis-arthritis [Accessed 03.10.2019]

Trade marks are owned by or licensed to the GSK group of companies.

About GSK Consumer Healthcare

GSK Consumer Healthcare is one of the world's largest consumer healthcare companies, responsible for some of the world’s best loved healthcare brands including Voltarol, Sensodyne, Corsodyl, Panadol, Poligrip and Otrivine.

About Voltarol

The Voltarol portfolio, from GlaxoSmithKline Consumer Healthcare, includes topical formulations to relieve pain so that consumers can enjoy the Joy of Movement. To learn more about body pain and how to relieve body pain effectively, go to www.voltarol.co.uk

CHGBI/CHVOLT/0203/19